Success Metrics

Active Trials
2(67%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

unknown133%
recruiting267%

Recent Activity

2 active trials
Showing 3 of 3
recruiting

Prediction of Cerebral Hyperperfusion Syndrome After Carotid Revascularization Using Deep Learning

NCT05800821
unknownnot_applicable

Carotid Revascularization Versus Best Medical Treatment for Asymptomatic Carotid Stenosis

NCT05623904
recruiting

Optimization Strategy of Carotid Artery Stenosis

NCT05629000

Clinical Trials (3)

Showing 3 of 3 trials
NCT05800821

Prediction of Cerebral Hyperperfusion Syndrome After Carotid Revascularization Using Deep Learning

Recruiting
NCT05623904Not Applicable

Carotid Revascularization Versus Best Medical Treatment for Asymptomatic Carotid Stenosis

Unknown
NCT05629000

Optimization Strategy of Carotid Artery Stenosis

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3